Congress urged to cut SEC 'red tape'
This article was originally published in Scrip
Executive Summary
Every dollar biotechs and other small innovators are being forced to spend on complying with Securities and Exchange Commission (SEC) regulations is money being taken away from research and development, said Representative Mike Fitzpatrick (Republican-Pennsylvania).